Health Condition 1: K769- Liver disease, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: esCCO device BSM9101 from Nihon Kohden Co., Ltd: The esCCO system by Nihon Kohden is a non-invasive monitoring technology used to estimate cardiac output
Sponsors
Dr Ekta Ranjan
Eligibility
Inclusion criteria
Inclusion criteria: 1 Age above 18 years 2 Post liver transplant patients with FloTrac monitor 3 Hemodynamic instability defined as MAP less than 65 mmHg or maintaining MAP greater than 65 mmHg with vasopressors
Exclusion criteria
Exclusion criteria: 1 Inability to perform PLR due to conditions such as raised intracranial pressure or intra abdominal hypertension 2 Cardiac arrhythmias during measurement 3 Aortic valvular abnormalities or use of intra-aortic balloon pumps or pacemakers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the correlation between cardiac output measurements derived from esCCO using pulse wave transit time and Flotrac using pulse contour analysis in post liver transplant recipients Timepoint: at baseline which is after three minutes of esCCO calibration | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the changes in cardiac output measured by both systems during passive leg raising testTimepoint: at one minute after PLR at one minute after reversal of PLR | — |
Countries
India
Contacts
Public ContactDr Deepak Govil
Medanta, The Medicity, Gurgaon
Outcome results
None listed